Figures
- FIGURE 1
Tuberculosis (TB) and HIV incidence in responding countries. TB low, HIV low (<10 cases per 100 000 population): Austria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Israel, Italy, Monaco, the Netherlands, Norway, Slovakia, Slovenia, Sweden, Switzerland, the UK. TB high, HIV low (<10 cases per 100 000 population): Albania, Armenia, Azerbaijan, Belgium, Bulgaria, Croatia, Kosovo, Lithuania, Macedonia, Montenegro, Romania, Serbia, Spain, Turkey. TB low, HIV high (≥10 cases per 100 000 population): Ireland and Luxembourg; TB high, HIV high (≥10 cases per 100 000 population): Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Malta, Moldova, Portugal, Ukraine, Uzbekistan. No response from: Andorra, San Marino (TB low, HIV low), Bosnia and Herzegovina, Poland (TB high, HIV low), Tajikistan (TB high, HIV high), Liechtenstein (no TB incidence, HIV low), Russian Federation, Turkmenistan (TB high, no HIV incidence). Map produced on December 14, 2018. Administrative boundaries: EuroGraphics and United Nations Food and Agriculture Organization.
- FIGURE 2
Overview of treatment providers and locations for the diagnosis and ambulatory treatment of tuberculosis (TB)/HIV patients. ID: infectious diseases; PLHIV: people living with HIV. #: one country did not provide the HIV testing and TB screening location.
Tables
- TABLE 1
Overview of respondents to the survey among TB and HIV Focal Points
TB Focal Points HIV Focal Points Total Separate responses by TB and HIV Focal Points# 12 12 12 Joint response by TB and HIV Focal Points 10 10 10 Response by TB Focal Point only 18 18 Response by HIV Focal Point only 7 7 No response 8 Total 40 29 55 Data are presented as n. #: discrepant results were identified by the authors and aligned by the responding Focal Points.
- TABLE 2
Country policies and recommendations on HIV testing, tuberculosis (TB) screening, latent TB infection (LTBI) testing, antiretroviral treatment (ART) and co-trimoxazole preventive treatment (CPT) based on the responses from 47 countries
TB incidence HIV incidence Total High Low All countries High 11+ 14§ 25 Low 2ƒ 20## 22 Policies and recommendations HIV test in TB patients# All patients High 11 (100) 13 (93) 24 Low 1 (50) 15 (75) 16 Selected patients High 0 (0) 1 (7) 1 Low 0 (0) 5 (25) 5 TB screening in PLHIV All patients High 11 (100) 11 (79) 22 Low 2 (100) 10 (50) 12 Selected patients High 0 (0) 3 (21) 3 Low 0 (0) 10 (50) 10 LTBI screening in PLHIV All patients High 5 (45) 13 (93) 18 Low 2 (100) 10 (50) 12 Selected patients High 3 (27) 1 (7) 4 Low 0 (0) 9 (45) 9 Not recommended High 3 (27) 0 (0) 3 Low 0 (0) 1 (5) 1 Start of ART in TB/HIV patients All patients High 11 (100) 13 (93) 24 Low 1 (50) 18 (90) 19 Selected patients High 0 (0) 1 (7) 1 Low 1 (50) 2 (10) 3 CPT of TB/HIV patients¶ All patients High 8 (73) 8 (57) 16 Low 0 (0) 3 (15) 3 Selected patients High 2 (18) 0 (0) 2 Low 1 (50) 4 (20) 5 Not recommended High 0 (0) 6 (43) 6 Low 0 (0) 10 (50) 10 Data are presented as n or n (% of total number of countries in the category). PLHIV: people living with HIV. #: one country did not respond to this question. ¶: five respondents were not familiar with their country's recommendation for CPT. +: high TB, high HIV: Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Malta, Moldova, Portugal, Ukraine, Uzbekistan. §: high TB, low HIV: Albania, Armenia, Azerbaijan, Belgium, Bulgaria, Croatia, Kosovo, Lithuania, Macedonia, Montenegro, Romania, Serbia, Spain, Turkey. ƒ: low TB, high HIV: Ireland, Luxembourg. ##: low TB, low HIV: Austria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Israel, Italy, Monaco, the Netherlands, Norway, Slovakia, Slovenia, Sweden, Switzerland, the UK.
Supplementary Material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary material 00721-2020.SUPPLEMENT
